MENU
+Compare
CMRX
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$8.54
Change
-$0.01 (-0.12%)
Capitalization
801.08M

CMRX Chimerix Forecast, Technical & Fundamental Analysis

Chimerix Inc... Show more

Industry: #Biotechnology
CMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CMRX with price predictions
Apr 17, 2025

CMRX in +0.35% Uptrend, rising for three consecutive days on April 15, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CMRX advanced for three days, in of 222 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 137 cases where CMRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CMRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.583) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. CMRX's P/S Ratio (3333.333) is very high in comparison to the industry average of (252.992).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CMRX is expected to report earnings to rise 6.68% to -26 cents per share on May 01

Chimerix CMRX Stock Earnings Reports
Q1'25
Est.
$-0.27
Q4'24
Est.
$-0.25
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.23
Q1'24
Missed
by $0.04
The last earnings report on March 21 showed earnings per share of -25 cents, missing the estimate of -24 cents. With 755.32K shares outstanding, the current market capitalization sits at 801.08M.
A.I. Advisor
published General Information

General Information

a developer of novel oral antiviral therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2505 Meridian Parkway
Phone
+1 919 806-1074
Employees
72
Web
https://www.chimerix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGIKX58.14N/A
N/A
Fidelity Growth & Income K
MAPOX104.07N/A
N/A
Mairs & Power Balanced
MMCFX14.19N/A
N/A
AMG Veritas China N
PGELX24.13N/A
N/A
George Putnam Balanced R5
APFDX19.47N/A
N/A
Artisan Global Discovery Investor

CMRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CMRX has been loosely correlated with QURE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CMRX jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMRX
1D Price
Change %
CMRX100%
N/A
QURE - CMRX
52%
Loosely correlated
N/A
NAMS - CMRX
49%
Loosely correlated
+2.86%
CRDF - CMRX
44%
Loosely correlated
-4.10%
AUPH - CMRX
37%
Loosely correlated
+2.41%
FGEN - CMRX
35%
Loosely correlated
+2.70%
More